Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1995-3-21
pubmed:abstractText
The reaction of dopamine beta-monooxygenase (DBM; EC 1.14.17.1) with the prototypical non-conjugated olefinic substrate, 2-(1-cyclohexenyl)ethylamine (CyHEA) [see Sirimanne and May (1988) J. Am. Chem. Soc. 110, 7560-7561], was characterized. CyHEA undergoes facile DBM-catalysed allylic hydroxylation to form (R)-2-amino-1-(1-cyclohexenyl)ethanol (CyHEA-OH) without detectable epoxidation or allylic hydroxylation to form (R)-2-amino-1-(1-cyclohexenyl)ethanol (CyHEA-OH) without detectable epoxidation or allylic rearrangement, and with stereochemistry consistent with that of DBM-catalysed benzylic hydroxylation and sulphoxidation. The kcat. of 90 s-1 for CyHEA oxygenation is about 75% of the kcat. for tyramine, the substrate commonly used in assays of DBM activity. DBM-catalysed oxygenation of CyHEA also results in mechanism-based inactivation of DBM, with the inactivation reaction yielding kinact. = 0.3 min-1 at pH 5.0 and 37 degrees C, and a partition ratio of 16,000. Although both CyHEA turnover and inactivation exhibit normal kinetics, CyHEA processing also results in gradual depletion of copper from DBM; however, mechanism-based irreversible DBM inactivation occurs independent of this copper depletion when sufficient copper is present in the assay solution. A likely mechanism for turnover-dependent DBM inactivation by CyHEA involves initial abstraction of an allylic hydrogen to form a resonance-stabilized allylic radical, which can then either partition to product or undergo attack by an active-site residue. Acyclic, non-conjugated olefinic analogues exhibit diminished substrate activity toward DBM. Thus, kcat. for oxygenation of cis-2-hexenylamine, which also produces only allylic alcohol product, is only 14% of that for CyHEA. Similarly, kinact./KI for turnover-dependent inactivation by the acyclic olefin 2-aminomethyl-1-pentene is more than an order of magnitude smaller than that for benzylic olefins. Our results establish that DBM catalyses allylic oxygenation of a number of non-conjugated olefinic substrate analogues with neither epoxidation nor allylic rearrangement occurring. The absence of epoxide products from non-conjugated olefinic substrates implies an inability of the activated copper-oxygen species of DBM to effect radical cation formation from a non-conjugated olefinic moiety. The striking contrast between DBM and cytochrome P-450, which carries out both epoxidation and allylic oxidation with non-conjugated olefinic substrates, is probably a reflection of the differences in redox potential of the activated oxygen species operative for these two enzymes.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-14416204, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-2729571, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-3007460, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-3036204, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-3101599, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-3335518, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-3593236, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-3607034, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-3612682, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-3626, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-3801416, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-3950911, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-3995005, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-4084493, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-4320820, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-4810500, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-4881884, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-4925832, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-6511785, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-6547439, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-6693426, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-6780561, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-6860408, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-7410403, http://linkedlifedata.com/resource/pubmed/commentcorrection/7864832-945283
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
306 ( Pt 1)
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
77-85
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Interaction of non-conjugated olefinic substrate analogues with dopamine beta-monooxygenase: catalysis and mechanism-based inhibition.
pubmed:affiliation
School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta 30332.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S.